Bausch + Lomb Executives to Address J.P. Morgan Healthcare Conference
Event summary
- Bausch + Lomb Chairman and CEO Brent Saunders, CFO Sam Eldessouky, and CMO Yehia Hashad will present at the 44th Annual J.P. Morgan Healthcare Conference.
- The presentation is scheduled for January 12, 2026, at 1:30 PM PT.
- A live webcast and archive will be available on the company's investor relations website.
- The conference is a significant gathering of healthcare investors and industry leaders.
The big picture
Participation in the J.P. Morgan Healthcare Conference signals Bausch + Lomb's continued focus on investor relations and transparency following its separation from Bausch Health. The presence of the CEO, CFO, and CMO suggests a comprehensive briefing intended to address key areas of investor interest, including financial performance, R&D progress, and strategic direction. This event is a key touchpoint for managing expectations and reinforcing the company's value proposition within a competitive landscape.
What we're watching
- Financial Outlook
- The presentation will likely be scrutinized for any revised guidance or commentary on the company's financial performance given recent market volatility and macroeconomic pressures.
- R&D Pipeline
- Investor attention will be focused on Yehia Hashad’s discussion of the R&D pipeline, particularly the progress and potential commercialization timelines for key products.
- Strategic Direction
- The conference provides an opportunity for Saunders to articulate the company's long-term strategic priorities and address any concerns regarding integration challenges or competitive pressures within the eye health market.
Related topics